Use of sodium-glucose cotransporter-2 (SGLT2) inhibitors does not appear to raise the risk for fractures in older adults, new research suggests. The data come from
Read moreHome ยป
Despite the extensive recent focus on its cost, insulin use in the United States remains dominated by insulin glargine and other analogs, as well as
Read moreAlmost half of young adults with type 2 diabetes develop a potentially blinding eye complication called diabetic retinopathy within a dozen years after diagnosis, new
Read moreON101 (Fespixon, Oneness Biotech), a first-in-class, macrophage-regulating, wound-healing cream for diabetic foot ulcers has shown benefit over absorbent dressings in a phase 3 trial, with
Read moreMillions of US adults aged 70 years and over previously advised to take aspirin for primary prevention would not now have it recommended for routine
Read moreNEW YORK (Reuters Health) – When metformin fails to sufficiently lower blood glucose levels, it’s better to add a sodium-glucose cotransporter 2 (SGLT2) inhibitor rather
Read moreStandard lifestyle interventions that offer benefits for most overweight patients with diabetes may in fact present a higher cardiovascular risk to a subset of patients
Read moreNEW YORK (Reuters Health) – In diabetic patients with critical limb ischemia (CLI), endovascular revascularization was associated with lower in-hospital mortality but more major amputations
Read moreThe practice of endocrinology appears to be too good for the state of mind, according to a new survey that places endocrinologists at the top of
Read more